Powered by

Japanese Red Cross Society Selects Abbott Technology to Screen Country's Blood and Plasma Supply

Jan 17, 2019 - PR Newswire

PR Newswire

Abbott (NYSE: ABT) announced today that it has been selected by the Japanese Red Cross Society (JRC) to partner in screening the country's blood donations. The 8-year contract is for the exclusive supply of serological instrumentation, tests and consumables used for blood and plasma screening. The JRC screens approximately 5 million blood donations each year, helping ensure a safe supply of products needed for blood transfusions and plasma therapies. Abbott's broad portfolio of...